Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02425 (Long intergenic non-protein coding RNA 2425) is an autonomously transcribed non-coding RNA gene that does not overlap annotated protein-coding genes. It is a member of the lincRNA family, characterized by transcripts longer than 200 nucleotides with no coding potential. The biological function of LINC02425 specifically remains uncharacterized, but lincRNAs in general play diverse roles in fine-tuning gene expression, organizing chromatin architecture, and may act as molecular scaffolds for protein or RNA interactions across different tissues. There is no current evidence for direct disease association, drug targeting, or use as a biomarker for LINC02425.
No defined drug mechanism for LINC02425. Mechanistic actions for lincRNAs may include scaffolding of protein complexes, modulation of transcription, RNA stability, and enhancer activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2425 (LINC02425).